$16M sweet spot round size
Most of their 9 investments are in rounds between $10M and $20M
2019
Xeltis raised $14M on August 14, 2023
Investors: EQT Life Sciences, Ysios Capital, VI Partners AG, Grand Patika and DaVita Venture Group
Dock Health raised $5M on May 25, 2023
Investors: Pladticam, MassMutual and DaVita Venture Group
Xeltis raised $34M on February 21, 2023
Investors: Grand Pharmaceutical (China) Co., Ltd., EQT Life Sciences, Invest-NL and DaVita Venture Group
Pathalys Pharma raised $150M on January 18, 2023
Investors: Catalys Pacific, OrbiMed Advisors, The Carlyle Group, Abingworth and DaVita Venture Group
Pathalys Pharma raised $11M on June 22, 2021
Investors: Catalys Pacific and DaVita Venture Group
Heartbeat Health raised $20M on May 10, 2021
Investors: ECHO, Designer Fund, Optum Ventures, Lerer Hippeau, Kindred Ventures, .406 Ventures, Max Ventures and DaVita Venture Group
Nephrosant, Inc. raised $16M on March 16, 2021
Investors: DigitalDx Ventures and DaVita Venture Group
SameSky Health raised $17M on December 15, 2020
Investors: Magnetic Ventures, Wanxiang America Corporation, 7wire Ventures, Salesforce Ventures, Tufts Health Plan, Impact Engine and DaVita Venture Group
Wellth raised $10M on May 6, 2020
Investors: New York Life Ventures, I2BF Global Ventures, Esplanade Ventures, yabeo, Partnership for New York City, MBX Capital, Distributed Ventures, Rock Health Capital and DaVita Venture Group